demonstrated that nine out of ten ARID1A mutated pancreatic cancers carry KRAS hotspot mutation G12D, suggesting that the inactivation of ARID1A may cooperate with KRAS in the early stages of pancreatic cancer formation (70). Here, ARID1A is linked to pancreatic neoplasm.